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ABSTRACT
During vertebrate development, mesodermal fate choices are regulated
by interactions between morphogens such as activin/nodal, BMPs and
Wnt/β-catenin that define anterior-posterior patterning and specify
downstream derivatives including cardiomyocyte, endothelial and
hematopoietic cells. We used human embryonic stem cells to explore
how these pathways control mesodermal fate choices in vitro. Varying
doses of activin A and BMP4 to mimic cytokine gradient polarization
in the anterior-posterior axis of the embryo led to differential activity
ofWnt/β-cateninsignalingandspecifieddistinctanterior-like (highactivin/
low BMP) and posterior-like (low activin/high BMP) mesodermal
populations. Cardiogenic mesoderm was generated under conditions
specifying anterior-like mesoderm, whereas blood-forming endothelium
wasgenerated fromposterior-likemesoderm,andvessel-formingCD31+
endothelial cellsweregenerated fromallmesodermorigins. Surprisingly,
inhibition of β-catenin signaling led to the highly efficient respecification
of anterior-like endothelium into beating cardiomyocytes. Cardiac
respecification was not observed in posterior-derived endothelial cells.
Thus,activin/BMPgradientsspecifydistinctmesodermalsubpopulations
that generate cell derivatives with unique angiogenic, hemogenic
and cardiogenic properties that should be useful for understanding
embryogenesis and developing therapeutics.
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INTRODUCTION
The anterior-posterior axis is the earliest to form in the embryo and
is evolutionarily most ancient (Kimelman and Martin, 2012).
Anterior primitive streak gives rise to endoderm, whereas the mid-
to posterior primitive streak gives rise to different mesodermal
lineages. Anterior mesoderm (mid-streak) gives rise to cardiac and
endocardial endothelium, whereas posterior mesoderm (posterior
streak) gives rise to the blood-forming endothelium and vasculature
(Murry and Keller, 2008).
Well-described anterior-posterior morphogen gradients,
including those of activin A/nodal and BMP4, are thought to
pattern mesoderm subtypes (Nostro et al., 2008; Sumi et al., 2008;
Kattman et al., 2011). Such gradients are proposed to specify
anterior mesodermal fates like cardiomyocytes versus posterior
mesodermal fates like blood. Remarkably, a recent study showed
that ectopic induction of a nodal/BMP gradient in zebrafish embryos
was sufficient to create an entirely new embryonic axis that could
run parallel, anti-parallel or orthogonal to the primary axis (Xu et al.,
2014). This provides compelling evidence that nodal and BMP are
significant determinants of anterior-posterior patterning in the
embryo.
Functionally, the TGFβ signaling family members activin A and
BMP4 synergistically activate Wnt/β-catenin signaling during
primitive streak (PS) formation, and are essential for establishing
downstream lineages (Nostro et al., 2008; Sumi et al., 2008).
Stimulation of the Wnt/β-catenin pathway during gastrulation is
required to form mesoderm (Yamaguchi et al., 1999; Lekven et al.,
2001), and the subsequent Wnt/β-catenin signaling gradients are
thought to be responsible for specifying sublineages of mesodermal
derivatives (Martin and Kimelman, 2012). Recent work has shown
that Wnt/β-catenin signaling is involved in redirecting fate choices
between mesodermal lineages in the post-gastrulation stage of
development (Schoenebeck et al., 2007; Van Handel et al., 2012;
Palpant et al., 2013).
In the present study we investigated whether unique functional
derivatives of mesoderm could be generated from human pluripotent
stem cells (hPSCs) in vitro by processes that reflect embryological
patterning during gastrulation. We modulated activin A, BMP4 and
Wnt/β-catenin signaling in order tomanipulate key cell fate transitions
from the undifferentiated state to mature cell types. Cardiomyocytes
were derived efficiently from anterior-likemesoderm, and bloodmore
efficiently fromposterior-likemesoderm. Endotheliumwas generated
from all mesodermal subtypes studied. These endothelial
subpopulations exhibit differences in hematopoietic, angiogenic,
and cardiogenic potential, reflecting influences of their developmental
ontogeny.
RESULTS
Patterning mesoderm in vitro using activin A/BMP4
Inspired by the dominant role of activin A and BMP4 in
establishing the anterior-posterior axis of the embryo (Sumi
et al., 2008; Xu et al., 2014), we hypothesized that titrating activin
A and BMP4 would modulate the strength of Wnt/β-catenin
signaling and thereby polarize mesoderm specification fromReceived 27 August 2014; Accepted 26 May 2015
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undifferentiated human embryonic stem cells (hESCs) along the
anterior-posterior axis (Fig. 1A). To analyze Wnt/β-catenin
signaling activity in mesoderm patterning, we used a RUES2
hESC line that expresses the green fluoroprotein Venus under
control of multimerized TCF/LEF elements (β-catenin-activated
reporter; BAR-Venus:UB-dsRed), as previously described
(Davidson et al., 2012; Palpant et al., 2013). We chose to monitor
the activity of the pathway through the BAR-Venus reporter in
combination with gene expression of Wnt modulatory proteins
during directed differentiation.
We tested the hypothesis that modulating activin A and BMP4
signaling could induce different types of mesoderm. hESCs were
differentiated using activin A at either 100 ng/ml (A100) or 50 ng/ml
(A50) in combinationwith a dose range ofBMP4between 5 ng/ml and
40 ng/ml (B5-B40) (a detailed schematic outlining the differentiation
methods employed in this manuscript is shown in supplementary
material Fig. S1). We found that concentrations lower than 50 ng/ml
activin A did not markedly influence mesoderm specification
(supplementary material Fig. S2). Based on previous work on
directed differentiation from hESCs, we have established that
mesoderm is specified on day 2 of differentiation (Paige et al.,
2010, 2012; Palpant et al., 2013). At this time point, analysis ofVenus
activity showed that differentiation with A100 caused significantly
lower activity of endogenous Wnt/β-catenin signaling than A50
(Fig. 1A-C). Consistent with this, analysis ofWnt/β-catenin signaling
modulators showedhighmRNAexpressionofWNT3A andWNT8A in
conditions ofA50,with increased levels of theWnt/β-catenin signaling
inhibitorDKK1 predominantly in conditions of A100 (supplementary
material Fig. S3A). By contrast, increasingBMP4concentrations only
modestly increased Wnt/β-catenin reporter activity and did not
significantly change the expression of Wnt regulators (Fig. 1C;
supplementary material Fig. S3A).
Other modulators of mesoderm patterning were analyzed by qRT-
PCR,which showed that the pan-mesodermmarkersKDR (VEGFR2)
and MESP1 are expressed across all conditions (supplementary
material Fig. S4A). Genes involved in anterior mesendoderm
development, including those encoding the bicoid homeobox
protein goosecoid (GSC) and NODAL, were more highly expressed
in conditions of A100 (Fig. 1D). This is consistent with studies
showing that NODAL functionally interacts with Wnt factors to
activate genes, such as GSC, that are required for anterior PS
patterning and germ layer formation (Reid et al., 2012). Conversely,
genes more highly expressed in posterior mesoderm, including
brachyury (T) and CDX1, a key modulator of Hox gene activity
(Lengerke et al., 2011) necessary for blood development (Wang et al.,
2008), were expressed more highly in conditions of A50 (Fig. 1E).
Using protein mass spectrometry, we analyzed day 2 mesoderm
generated by different induction approaches. These data show a high
degree of similarity between the mesodermal subtypes, with the
exception of several molecules that are significantly different and
reinforce the observation that proteins involved in anterior versus
posterior mesoderm patterning are appropriately expressed in a
lineage-specific manner (Fig. 1F). Specifically, fibronectin 1 (FN1)
was highly expressed under conditions of A50/B40. Although FN1 is
functionally required for organ development in a wide range of
tissues, it is functionally required in posterior but not anterior lateral
plate mesoderm development during gastrulation (George et al.,
1993). Furthermore, the T-box transcription factor eomesodermin
(EOMES) acts upstream of MESP1 to direct cardiogenic mesoderm
(Costello et al., 2011) and MIXL1 is functionally required for the
morphogenesis of axial mesoderm and represses posterior
mesoderm fates (Hart et al., 2002). As such, these proteins are
appropriately expressed in conditions of A100/B5.
Taken together, gene expression analysis, proteomic analysis,
and Wnt/β-catenin signaling activity support the notion that
modulating the concentration of activin A/BMP4 can polarize
mesoderm along the anterior-posterior axis in vitro from human
pluripotent stem cells.
Specification of cardiogenic mesoderm from anterior
mesoderm
Using this dosing regimen of activin A/BMP4, we next sought to
directly assess the effect on downstream mesodermal derivatives
using cardiomyocytes as readouts of anterior differentiation. The
Fig. 1. Directing mesoderm patterning by titrating
activin A and BMP4. (A) The experimental approach for
directing undifferentiated hESCs into anterior versus
posterior mesoderm using doses of activin A and BMP4.
(B) The BAR-Venus:Ub-dsRed vector used to measure
endogenous Wnt/β-catenin signaling in differentiating
hESCs. (C) Changes in mean fluorescence intensity of
BAR-Venus activity on day 2 of directed differentiation
under different activin A/BMP4 conditions (left), and a
representative flow plot showing reporter activity in
conditions of 100 ng/ml activin A and 5 ng/ml BMP4
(A100/B5) versus 50 ng/ml activin A and 40 ng/ml BMP4
(A50/B40) (right). (D,E) qRT-PCR analysis of genes involved
in mesoderm patterning, including anterior mesoderm
markers NODAL and GSC (D) as well as posterior markers
CDX1 and brachyury (T) (E). n=5 biological replicates for
BAR-Venus activity and qPCR analysis. *P<0.05.
(F) Volcano plot showing proteins significantly differentially
expressed between day 2 A50/B40 and A100/B5 cells using
an FDR threshold of 0.05. For mass spectrometry n=2
biological replicates, eachwith three technical replicates per
sample.
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protocol for cardiac directed differentiation is based on studies from
our laboratory and others showing that cardiac specification
involves a biphasic modulation of Wnt/β-catenin signaling.
Specifically, robust Wnt/β-catenin signaling activation is required
to direct mesoderm, and specification into the cardiac lineage
involves downregulation of Wnt/β-catenin signaling (Ueno et al.,
2007; Paige et al., 2010; Lian et al., 2012; Palpant et al., 2013). The
protocol used for directing cardiac differentiation is detailed in the
supplementary Materials and Methods and Fig. S1.
Analysis at day 14 showed that the highest efficiency of
cardiac differentiation occurred under conditions of A100/B5 [90
±1% cTnT (TNNT2)+ cardiomyocytes] (Fig. 2A-D). By contrast,
cardiomyocyte differentiation progressively decreased with lower
doses of activin A and higher doses of BMP4, with purity dropping
as low as 14±6% cTnT+ cells when initiated under conditions of
A50/B40 (Fig. 2A,B). Analysis of day 5 cardiac progenitor cells
(CPCs) did not show any correlation of KDR+/PDGFRα+ cells and
cardiac differentiation efficiency under these differentiation
conditions (supplementary material Fig. S4B,C).
To determine the effect of induction on cardiac cell fate
specification, we compared the expression profiles of day 14
cells induced with either A100/B5 or A50/B40, with subsequent
differentiation under cardiogenic conditions (supplementary
material Fig. S5). RNA-seq data indicate that A100/B5 cells give
rise to a cardiac phenotype as expected. By contrast, A50/B40 cells
at day 14 showed a robust endothelial phenotype. These data
indicate that induction conditions are deterministic with regard to
fate potential, such that cardiogenic mesoderm is specified early
from A100/B5 conditions and an endothelial fate is specified from
A50/B40 conditions.
To understand the role of Wnt/β-catenin signaling under cardiac
differentiation conditions, we analyzed BAR-Venus reporter activity
in day 5 CPCs (Fig. 2C; supplementary material Fig. S3B,D).
Compared with the peak of mesoderm formation at day 2, there was
a significant downregulation of Wnt/β-catenin signaling in day 5
cells, with the greatest downregulation occurring in CPCs initiated
under A100 conditions (Fig. 2C; supplementary material Fig. S3D).
Compared with day 2, gene expression analysis of Wnt modulators
in day 5 CPCs showed a significant downregulation of canonical
Wnt ligands but a marked increase in canonical Wnt inhibitors
including TMEM88 and WNT5A in A100 conditions (supplementary
material Fig. S3B). Importantly, we also observed a significant
increase in expression of the canonical Wnt/β-catenin inhibitor
DKK1 in anterior-derived cardiogenic mesoderm, which suggests a
more repressive state of Wnt/β-catenin signaling during cardiac
specification (supplementary material Fig. S3B).
Derivation of endothelium
Given that factors involved in hemato-endothelial mesoderm
development, such as CDX1 and WNT8A, had an inverse
correlation with cardiac differentiation efficiency (Fig. 1E;
supplementary material Fig. S3A), we hypothesized that this
mesodermal differentiation platform could be used to direct
downstream vascular fate choices and efficiently generate blood
and endothelial cells. Since endothelium is generated from all
mesodermal origins (Murry and Keller, 2008), we sought to
understand the impact on cell fate decisions of endothelial
development after initiating differentiation with different
concentrations of activin A and BMP4. We tested a wide range of
culture conditions involving stimulation with major determinants
of endothelial fate, including varying the timing and concentrations
of VEGF, BMP4, CHIR-99021 and FGF, based on previous studies
describing endothelial differentiation from PSCs (Kennedy et al.,
2007, 2012; Choi et al., 2012; Rafii et al., 2013; White et al., 2013)
(supplementary material Fig. S7; data not shown). Studies from our
lab and others have established a role forWnt/β-catenin signaling in
specifying endothelial commitment (Woll et al., 2008; Palpant
et al., 2013; Sturgeon et al., 2014). We observed, however, that
addition of the small moleculeWnt/β-catenin agonist CHIR-99021
between days 2 and 5 inhibited endothelial fate specification,
indicating that other factors involved in the specification of
endothelium tightly orchestrate the dosage of Wnt/β-catenin
signaling (supplementary material Fig. S7). We describe in detail
our protocol for endothelial differentiation in the supplementary
Materials and Methods and Fig. S1.
In our optimized protocol, analysis of pan-endothelial markers on
day 5 of differentiation showed that we could generate greater than
90% KDR+/CD34+ double-positive cells (Fig. 3A,B). These data
show that a high percentage of KDR+/CD34+ cells can be generated
across the full spectrum of activin A and BMP4 conditions used to
establish mesoderm patterning at the onset of differentiation.
Fig. 2. High activin A and low BMP4 concentrations direct cardiac
differentiation. (A,B) Flow cytometry for cTnT on day 14 of differentiation
across the range of differentiation conditions defined by doses of activin A and
BMP4, with raw histograms (A) and mean data across five biological replicates
(B) showing the highest efficiency of cardiac differentiation (percentage cTnT+
cardiomyocytes) in conditions of A100/B5. (C) Wnt/β-catenin signaling activity
as measured by the BAR-Venus reporter in day 5 CPCs under different doses
of activin A and BMP4. Inset shows raw flow cytometry plot of Venus activity in
A100/B5 versus A50/B40 CPCs. (D) Schematic illustrating that cardiomyocytes
are generated optimally fromA100/B5CPCs. n=5 biological replicates. *P<0.05.
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Consistent with endothelial development, a high percentage of these
cells express VE-cadherin (Fig. 3C). We next assessed whether these
endothelial cells exhibited molecular characteristics of developing
endothelium (Shalaby et al., 1997; Wu et al., 2011; Nakano et al.,
2013). Key markers involved in vascular and blood development,
including the master transcription factor of hemato-endothelial
development SCL (TAL1), as well as VE-cadherin (CD144, or
CDH5), CD34, RUNX1 and GATA1, were significantly upregulated
between days 2 and 5 in both populations of KDR+/CD34+ cells, but
not under cardiac differentiation conditions (Fig. 3D).
Analysis of BAR-Venus activity indicated that Wnt/β-catenin
signaling was markedly elevated in day 5 KDR+/CD34+ cells
compared with day 5 CPCs (supplementary material Fig. S3D).
Furthermore, the posterior A50/B40 KDR+/CD34+ cells had
significantly higher Wnt/β-catenin signaling activity than the
anterior A100/B5 KDR+/CD34+ cells (Fig. 3E; supplementary
material Fig. S3D). Analysis of Wnt regulatory molecules
indicated that, although expression of the Wnt ligands WNT3A
and WNT8Awas reduced in KDR+/CD34+ cells, as seen in cardiac
differentiation, the expression levels of Wnt/β-catenin signaling
inhibitors such as TMEM88, WNT5A and DKK1 were reduced in
KDR+/CD34+ cells compared with CPCs (supplementary material
Fig. S3A-C). These data indicate that Wnt/β-catenin signaling
dosage does not appear to influence endothelial differentiation, but
we hypothesized that differences in Wnt/β-catenin signaling might
be crucial for specifying endothelial subtypes.
In keeping with the hypothesis that Wnt/β-catenin signaling
dosage may participate in the specification of different endothelial
subtypes, we analyzed molecular markers of endocardial versus
vascular endothelial fate. Recent fate-mapping data have suggested
that NFATC1 and GATA4 are markers of anterior-derived
endocardial endothelium and distinguish it from posterior-derived
vascular hemogenic endothelium (Misfeldt et al., 2009; Peterkin
et al., 2009). Consistent with this, Nfatc1 knockout mice die mid-
gestation due to endocardial valve malformation-induced heart
failure (de la Pompa et al., 1998; Ranger et al., 1998; Misfeldt et al.,
2009; Wu et al., 2011). We found the cardiogenic factor GATA4
expressed only in anterior-derived mesodermal derivatives
(Fig. 3D) and NFATC1 was significantly elevated in anterior
A100/B5 KDR+/CD34+ cells (Fig. 3F).
By contrast, lineage-tracing studies have identified a role for
HAND1 in cardiomyocyte development and posterior mesoderm
development but not in endocardial development (Morikawa and
Cserjesi, 2004; Barnes et al., 2010; Maska et al., 2010). Reflecting
this cell fate, we found that HAND1 is significantly upregulated in
the posterior A50/B40 KDR+/CD34+ cells (Fig. 3G). We analyzed
the expression of additional vascular development markers known
to be involved in arterial specification, including SOX17, EFNB2
and CXCR4. However, we found no difference in the expression of
these molecules based on induction method (supplementary
material Fig. S4D).
Taken together, these data show that KDR+/CD34+ cells
can be generated with equal efficiency across a range of activin
A/BMP4 dosing regimens with molecular differences that
suggest an endocardial versus vascular endothelial lineage fate
(Fig. 3H).
Anterior and posterior endothelial cells exhibit overlapping
as well as lineage-specific endothelial function
On the basis of these findings, we carried out secondary assays to
assess the functionality of day 5 A100/B5 and A50/B40 endothelial
cells (ECs) (Fig. 4). CD34+ sorted or unsorted day 5 cells were
plated on gelatin-coated plates in endothelial growth medium
(EGM) containing VEGF, bFGF (FGF2) and the GSK3 inhibitor
CHIR-99021 for 9 days. Under these conditions, A100/B5 and
A50/B40 ECs both gave rise to greater than 95% pure CD31
(PECAM1)+ ECs by flow cytometry analysis (supplementary
material Fig. S8A). Culturing day 5 cells after FACS for CD34+
cells did not improve CD31+ cell purity compared with unsorted
cells (supplementary material Fig. S8A). Both populations of
ECs showed expression of appropriate markers, including CD31
and the endothelial marker von Willebrand factor (VWF), and no
Fig. 3. KDR+/CD34+/VE-cadherin+ cells are generated efficiently across
doses of activin A and BMP4. (A-C) Flow cytometry plots (A) and mean data
for the percentage of cells double positive for KDR and CD34 (B) or for KDR
and VE-cadherin (C). (D) qRT-PCR analysis across the timecourse of days 2-5
of differentiation comparing A100/B5-derived CPCs with A100/B5-derived
KDR+/CD34+ cells and A50/B40-derived KDR+/CD34+ cells. CD144 refers to
VE-cadherin. (E) Wnt/β-catenin signaling activity as measured by the BAR-
Venus reporter in day 5 KDR+/CD34+ cells under different doses of activin A
and BMP4 (left), with representative raw flow cytometry plot of Venus activity in
A100/B5 KDR+/CD34+ versus A50/B40 KDR+/CD34+ cells (right). (F,G) qRT-
PCR analysis for markers of endothelium including NFATC1 (F) and HAND1
(G). (H) Schematic showing lineage differentiation for directing undifferentiated
hESCs into A100/B5-derived KDR+/CD34+ cells and A50/B40-derived
KDR+/CD34+ cells. n=3-8 replicates per sample for all assays. *P<0.05.
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significant difference in proliferation (supplementary material
Fig. S8B,C).
We carried out functional assays to determine whether
differentiated ECs from both lineages showed evidence of
sprouting angiogenesis or tube formation in vitro. Day 14 A100/B5
and A50/B40 ECs were plated as a monolayer on collagen (2 mg/ml)
to assess gel invasion/sprouting or embedded within collagen to
assess tube formation (Fig. 4B,C). Orthogonal views show that both
populations of ECs have the capacity for sprouting angiogenesis
based on invasion into the collagen matrix and tube formation based
on de novo lumen formation (Fig. 4B,C).
To assess the ability of these cells to respond to fluid shear stress,
we analyzed the function of day 14 A100/B5 and A50/B40 ECs when
seeded into microfabricated engineered vessels as previously
described (Zheng et al., 2012) (Fig. 4D). The cells were seeded
into microfluidic channels to form a templated microvascular
network with a perfusable lumen and cultured for 4 days under
gravity-driven flow. Surprisingly, A100/B5 ECs showed robust
sprouting activity with de novo angiogenic vessels. By contrast,
A50/B40 ECs had minimal angiogenic potential under the same
conditions (Fig. 4Di). Immunohistochemical analysis of these
engineered vessels showed similar expression of CD31 and
VWF in both populations (Fig. 4Dii). By contrast, under these
conditions, expression of VE-cadherin was found exclusively
within the non-sprouting A50/B40 ECs (Fig. 4Diii), consistent
with the finding that shedding of VE-cadherin is associated with
in vivo angiogenesis (Reiss and Saftig, 2009). However, we
cannot exclude the possibility that this observation might also
be due to instability of the endothelial phenotype, as previously
reported (James et al., 2010), or a consequence of sustained
culture and passaging. Quantification of sprouting angiogenic
potential showed that in static culture conditions (monolayer
invasion assay) there was no significant difference in the
number and length of sprouts between the two populations of
ECs (Fig. 4E). By contrast, in engineered vessels under flow
conditions, A100/B5 ECs showed a significantly higher number
and length of sprouts than A50/B40 ECs (Fig. 4E). These data
show that, although there are a number of functional similarities
between these endothelial populations, marked differences do
exist between them when placed under conditions of flow.
Fig. 4. KDR+/CD34+ cells can differentiate into functional endothelium. (A) Experimental approach for directing undifferentiated hESCs into A100/B5 and
A50/B40 ECs and then into differentiated and functional ECs. (B,C) Day 14 A100/B5 and A50/B40 ECs were plated onto collagen as a monolayer to assay sprouting
angiogenic potential (B) or embedded into collagen to assay tube formation potential (C). Orthogonal views (at the dashed line) are shown beneath as a z-stack in
the xz axis. (D) Day 14 A100/B5 and A50/B40 ECs were seeded into engineered microvessels (i) and exposed to flow for 4 days. Engineered microvessels were
assayed for vessel structure and cellular expression of VWF and CD31 (ii) as well as VE-cadherin (iii) together with a nuclear counterstain. Orthogonal views are
shown to the side as a z-stack of the yz axis. (E) Quantification of the number and length of sprouting vessels in monolayer and engineered vessels. n≥3 replicates
per sample. *P<0.05; NS, not significant. Scale bars: 100 µm, except 500 µm in Di.
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Anterior and posterior ECs have different hematopoietic
potential
Since a subset of endothelium (termed ‘hemogenic endothelium’) is
known to give rise to hematopoietic cells in the developing embryo
in vivo and during PSC differentiation in vitro (Jaffredo et al., 1998;
Nishikawa et al., 1998; Lancrin et al., 2009; Choi et al., 2012; Rafii
et al., 2013; Slukvin, 2013), we analyzed the blood-forming
potential of A100/B5 and A50/B40 ECs (Fig. 5). Previous studies have
suggested that hemogenic endothelium is confined to the portion of
ECs negative for the surface marker CD73 (NT5E) (Choi et al.,
2012). We found that both A100/B5 and A50/B40 ECs include a
population that is CD31+/CD73−, although in differing proportions,
consistent with a possible hemogenic phenotype (Fig. 5B,C).
We next examined the hematopoietic potential of A100/B5 and
A50/B40 ECs over time. To determine if day 5 cells contained
hematopoietic progenitors, we analyzed cells by flow cytometry for
hematopoietic surface markers and by methylcellulose assays for
colony-forming unit (CFU) progenitor potential. The day 5 A50/B40
EC population already contained a subset of cells expressing the
earliest hematopoietic markers CD43 (SPN) and CD235a (GYPA)
and, to a lesser extent, CD41 (ITGA2B) (Fig. 5D-F). This is
consistent with a primitive hematopoietic phenotype (Vodyanik
et al., 2006; Kennedy et al., 2012; Slukvin, 2013). By contrast, the
A100/B5 ECs at day 5 lacked significant expression of CD43. As
expected, neither population at this early time point exhibited
significant CD45 (PTPRC), which is typically expressed later in
hESC hematopoietic differentiation concomitant with broader
myeloid potential (Vodyanik et al., 2006; Kennedy et al., 2012).
Consistent with their primitive hematopoietic phenotype, the day 5
A50/B40 ECs generated progenitors that produced small, primitive
erythroid-like (CFU-EryP) and macrophage (CFU-Mac) colonies in
methylcellulose assays, whereas the A100/B5 ECs generated
minimal CFU progenitors at this time point (Fig. 5F,I).
To further assay the capacity of A100/B5 and A50/B40 ECs for later
erythromyeloid hematopoietic potential, day 5 cells from both
populations were plated secondarily on OP9 stromal cells with
hematopoietic cytokines. After 12-14 days of co-culture, cells were
analyzed for hematopoietic phenotype and colony-forming
progenitors. A50/B40 ECs generated a population of predominantly
CD45+ hematopoietic cells following OP9 co-culture, a subset of
which co-expressed CD34, with minimal populations expressing
CD235a and/orCD41 (Fig. 5G-I). Consistentwith this hematopoietic
phenotype, A50/B40 ECs generated mostly myeloid CFUs consisting
of both granulocyte/monocyte (GM) andmacrophage (Mac) types, as
well as larger erythroid burst-forming units (BFU-E) and mixed
colonies containing both erythroid and myeloid elements (Mix)
(Fig. 5I). By contrast, the A100/B5 ECs generated relatively limited
numbers of CD45+ cells and few CFU progenitors (Fig. 5G-J).
Interestingly, when assayed at an intermediate time point during OP9
co-culture (5 days), the A100/B5 ECs did generate a transient
population of CD43+/CD235a+ cells and CFUs consisting of the
primarily primitive erythroid type (supplementary material Fig. S9).
Under these conditions, compared with A100/B5 ECs, A50/B40 ECs
showed significantly higher levels of CD45+ cells, CFU-Mac and
CFU-GM.
These findings suggest limited hematopoietic potential of the
A100/B5 ECs, appearing later than that detected from A50/B40 ECs.
This is consistent with a recent report suggesting transient
hematopoietic activity of anterior mesoderm-derived endocardium
during murine development (Nakano et al., 2013). Although this
hematopoietic activity was detected even when the day 5 A100/B5
ECs were sorted for CD34 expression (data not shown), we cannot
rule out the possibility of a hematopoietic contribution derived from
a small number of less differentiated mesoderm cells among the day
5 A100/B5 ECs. Overall, however, our results suggest that
hematopoietic activity is enriched within the A50/B40 relative to
A100/B5 ECs, consistent with the primary origin of embryonic
hematopoiesis from posterior mesoderm.
Respecification of endothelium into cardiomyocytes by
inhibition of Wnt/β-catenin signaling
Studies have suggested that cardiac and hemogenic-endothelial
lineages are closely related in the genetic and signaling mechanisms
that mediate their development (Lin et al., 1998; Ferdous et al.,
2009; Gekas et al., 2009; Lian et al., 2012; Van Handel et al., 2012;
Chan et al., 2013; Kim et al., 2013; Palpant et al., 2013). Work from
our laboratory and others indicates that activation of the Wnt/β-
catenin signaling pathway is sufficient to convert cardiomyocyte
progenitors into hemogenic ECs (Schoenebeck et al., 2007; Van
Handel et al., 2012; Palpant et al., 2013). Based on these findings,
we tested the reciprocal hypothesis that blocking Wnt/β-catenin
signaling is sufficient to convert endothelium derived from our two
distinct subpopulations into the cardiac lineage. hESCs were
induced to differentiate using either A100/B5 or A50/B40, followed
by hemogenic endothelial differentiation conditions from days 2-5
(described above). From day 5-14 of differentiation, the medium
was changed to RPMI with B27 supplement, in keeping with
standard cardiac differentiation methods. In the absence of Wnt/β-
catenin inhibition, A100/B5 ECs showed some intrinsic capacity
to convert into cardiomyocytes (Fig. 6A), whereas no cardiogenic
activity was present in the A50/B40 ECs. Gene expression analysis
of day 5 A100/B5 ECs suggests that the cells are primed for
cardiogenesis, based on the expression of cardiac-related genes
such as GATA4 (Fig. 3E) and MYL7 (supplementary material
Fig. S4D).
To suppress Wnt/β-catenin signaling, we tested a wide range of
conditions in which cells were exposed to varying doses of the small
molecule tankyrase inhibitor XAV-939 (XAV) during differentiation.
Strikingly, inhibition of Wnt/β-catenin signaling with 2 µM XAV
between days 5 and 7 of differentiation yielded 90% beating
cardiomyocytes from anterior A100/B5 ECs (Fig. 6A; supplementary
material Fig. S10A). In marked contrast, inhibiting Wnt/β-catenin
signaling in posterior A50/B40 ECs did not induce cardiomyocyte
development (Fig. 6A; supplementary material Fig. S10B).
qPCR analysis showed that both endothelial populations, but
not A100/B5 CPCs, have high-level expression of lineage markers
including SCL and VE-cadherin on day 5 of differentiation
(Fig. 6B). By day 8 (3 days post Wnt/β-catenin inhibition) these
makers were significantly downregulated in ECs. By contrast,
A100/B5 CPCs never expressed endothelial markers but showed
appropriate activation of cardiomyocyte development on the
basis of NKX2.5 and cTnT expression (Fig. 6B). Among the
endothelial populations, only the anterior A100/B5 ECs showed an
upregulation of cardiac lineage markers after treatment with XAV,
comparable to A100/B5 CPCs (Fig. 6B). Flow cytometry for cTnT+
cells at the day 14 time point showed that no cardiomyocytes
were produced from A50/B40 ECs treated with XAV (Fig. 6C).
By contrast, significant cardiomyocyte production was generated
via A100/B5 CPCs and XAV-treated A100/B5 ECs, with no
difference in purity between these approaches (cTnT+ cells
generated by: A100/B5 CPCs, 81±1%; A100/B5 ECsXAV, 72±2%;
A50/B40 ECsXAV, 1±0%; Fig. 6C). There was also no difference in
the onset of beating during differentiation or in the intrinsic
beating rate (supplementary material Movie 1 and Fig. S11A,B).
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Cardiomyocytes generated from XAV-treated A100/B5 ECs
showed slightly lower cardiomyocyte cell yield than A100/B5
CPCs (Fig. 6D).
Immunohistochemistry showed clear myofibrillar striations in
both cardiomyocyte populations on the basis of α-actinin expression
as well as nuclear-localized NKX2.5 (Fig. 6E). By contrast,
these cardiac markers were not detected in the XAV-treated
posterior A50/B40 ECs (Fig. 6E). These findings indicate that
there is a cardiogenic lineage bias among ECs and CPCs derived
from A100/B5 conditions (Fig. 6F).
We performed genome-wide transcriptional analysis by RNA-seq
to determine similarities and differences between cardiomyocytes
generated from A100/B5 CPCs and cardiomyocytes derived from
XAV-treated A100/B5 ECs (Fig. 7A). These data show significant
differences between the populations in the areas of extracellularmatrix
proteins, cell cycle regulation, and membrane signaling/glycoprotein
components (Fig. 7B).Despite their origin fromECs, theXAV-treated
A100/B5 ECs showed striking similarity in their cardiac gene
expression profiles, including those encoding calcium-handling
proteins (e.g. CACNA1C, ATP2A2), myofilament proteins (e.g.
TNNI1, cTnT) and transcription factors (e.g. HAND2, GATA4,
MEF2C, NKX2.5) (Fig. 7C,E; supplementary material Tables S1
and S2). Some cardiac geneswere significantly different in expression
between these populations and suggested a more mature ventricular
phenotype in XAV-treated A100/B5 ECs compared with A100/B5
CPCs. These include genes encoding proteins such as MYL2 and
MYH7, gap junction, ion channel and calcium-handling proteins
(GJA1, GJA5, KCNN4, CASQ2), the cardiac maturation factor
HOPX, as well as the first heart field transcription factor TBX5
(Fig. 7D,F). RNA-seq analysis ofXAV-treatedA50/B40ECs indicated
that, although endothelial markers were downregulated after Wnt/β-
catenin inhibition (Fig. 6B), this population continued to show
evidence of its endothelial-like state as indicated by the enrichment of
endothelial gene ontology categories (supplementary material
Fig. S5). Our data cannot distinguish epigenetic memory from a
mixed population at this point.
We carried out several experiments in order to understand the
nature of this cell fate conversion in greater detail. First, we tested
whether cell fate conversion could occur if Wnt/β-catenin
inhibition was introduced at earlier time points in differentiation,
which would suggest that uncommitted mesoderm cells are giving
rise to the cardiomyocytes. These results show that Wnt/β-catenin
Fig. 5. Day 5 ECs have hematopoietic potential. (A) The experimental approach for directing undifferentiated hESCs into A100/B5 and A50/B40 ECs followed
by differentiation into blood cells. (B,C) Representative flow cytometry plots (B) and mean percentages (C) of CD73+ and CD73− subsets of CD31+ A100/B5 and
A50/B40 ECs (n=6 replicates). (D-F) Representative flow cytometry plots of hematopoietic phenotypes CD34/CD45, CD41/CD235a within the CD43 subset (D),
mean numbers of cells of primitive phenotype (CD43+/CD235a+/CD41+/−) (n=6 replicates) (E), and colony-forming assays for primitive hematopoietic progenitors
including primitive erythroid (EryP) and macrophage (Mac) (n=3 replicates) (F) generated from day 5 A100/B5 and A50/B40 ECs. (G-I) Representative flow
cytometry plots of hematopoietic phenotypes CD34/CD45, CD41/CD235a within the CD43 subset (G), mean numbers of CD45+ hematopoietic cells generated
(n=6 replicates) (H), and colony-forming assays for definitive erythroid/myeloid hematopoietic progenitors including macrophage (Mac), granulocyte/monocyte/
macrophage (GM), large, burst-forming erythroid (BFU-E), and mixed erythroid/myeloid (Mix) colonies (n=3 replicates) (I) generated from 105 A100/B5 ECs or
A50/B40 ECs following 12-14 day secondary culture onOP9 cells. (J) Representative images for colony-forming assays. Images aremagnified for EryP (100×) and
Mac (50×) to show details of colony morphology.
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inhibition at day 3 of differentiation (the time point when XAV is
added in cardiac differentiation) does not result in efficient
fate conversion, arguing against residual uncommitted mesoderm
cells (supplementary material Fig. S10A). Not until day 5, when
the cells are fully committed hemogenic endothelium (>90%
KDR+/CD34+), do we observe a robust capacity for conversion to
the cardiac fate. The capacity for cell fate conversion diminishes as
the cells mature toward the endothelial fate (supplementary
material Fig. S10C).
Second, we were able to convert ECs to cardiomyocytes using
various media, including endothelial growth medium (EGM),
Stempro34 with cardiac supplement, as well as RPMI with B27
supplement (supplementary material Fig. S12). This indicates that
the capacity for cell fate conversion from ECs is primarily
determined by Wnt/β-catenin inhibition and not other cardiogenic
factors in the media. Furthermore, we show that increasing doses of
XAV do not markedly alter the number of live cells during the cell
fate conversion, indicating that the cardiomyocytes generated are
not the consequence of selection of a cardiogenic subset caused by
the death of non-cardiogenic cells (supplementary material Fig.
S11D).
Lastly, we tested by FACS whether cardiac fate conversion
from endothelium was attributable solely to the CD34+ population,
and found that cardiomyocytes were generated exclusively from
the CD34+ population and not from the CD34− population
(supplementary material Fig. S11C).
DISCUSSION
PSCs provide a promising source of human cells for therapeutic
applications. Although cellular plasticity is one of the most exciting
features of these cells, directing their specific fate efficiently presents a
major challenge. In the current study, we show that titrating activin A
and BMP4 dosage results in modulation of Wnt/β-catenin signaling
activity at the onset of fate specification. This induction approach has
dramatic implications for generating different populations that reflect
the embryological patterning of anterior and posterior mesodermal
lineages. The lineage bifurcations that occur as a consequence of the
different induction signals enable the specification of progenitor
Fig. 6. InhibitingWnt/β-catenin signaling redirects A100/B5 ECs but not A50/B40 ECs into the cardiac fate with high efficiency. (A) Flow cytometry analysis
of cTnT+ cells from ECs treated with increasing doses of XAV-939 between days 5 and 7 of differentiation. (B) qRT-PCR analysis of SCL, VE-cadherin (CD144),
NKX2.5 and cTnT between differentiation days 5 and 14, comparing the lineage potential from day 5 cultures derived from A100/B5 CPCs, A100/B5 ECsXAV
and A50/B40 ECsXAV. (C) Percentage of cardiomyocytes assessed by flow cytometry for the myofilament protein cTnT among day 14 cells. (D) Cardiomyocyte
yield generated from A100/B5 CPCs, A100/B5 ECsXAV and A50/B40 ECsXAV. (E) Immunohistochemistry for α-actinin and NKX2.5 in day 14 cells generated from
A100/B5 CPCs, A100/B5 ECsXAVand A50/B40 ECsXAV. Scale bar: 100 µm. (F) Schematic illustrating that A100/B5 CPCs and A100/B5 ECsXAVare lineage biased to the
cardiac fate compared with A50/B40 ECsXAV. n=5-6 replicates per sample. *P<0.05 versus all other groups.
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populations that are capable of giving rise to high-purity definitive
mesodermal derivatives such as cardiomyocytes and ECs
(supplementary material Fig. S1). We found variability in the
efficiency of differentiation using these protocols between various
hPSC lines, indicating the need for line-by-line optimization. Our
approach utilizing changes in activin A and BMP4 concentration
shows that these morphogens act both in a coordinated fashion and
independently to orchestrate the complex aspects of lineage fate
choice in mesoderm development.
Analogous to embryological events, we show that cardiac
differentiation occurs most efficiently under conditions that specify
an anterior-like cardiogenic mesoderm. We also show that KDR+/
CD34+/VE-cadherin+ ECs are generatedwith equal potency across all
conditions of activin A/BMP4 dosing. This is consistent with the
observation that endothelial lineages are derived from a range of
embryological origins (Wu et al., 2011; Nakano et al., 2013). Studies
have shown that endocardial endothelium is derived from the anterior
mesoderm in coordination with the heart-forming fields, whereas
vascular endothelium involved in formation of the dorsal aorta, aorta-
gonad-mesonephros (AGM) and yolk sac vasculature is generated
from the posterior mesoderm (Walmsley et al., 2002; Schoenebeck
et al., 2007; Misfeldt et al., 2009).
Although KDR and CD34 expression does not distinguish
between these populations, we show mRNA differences in
NFATC1 and HAND1 expression that do suggest a polarizing
effect of activin A/BMP4 titration on endothelial subtypes. Our
findings indicate that establishing a polarization of mesoderm at
the onset of differentiation is required to specify sublineages of
endothelial fate that have unique phenotype and function.
Anterior ECs showed significantly higher angiogenic behavior
under flow, with diminished VE-cadherin junctions at cell-cell
contacts, whereas posterior ECs strongly expressed VE-cadherin
with minimal sprouting under flow. EC responses to flow
have been shown to occur, in part, through a junctional
mechanosensory complex consisting of VE-cadherin, CD31 and
KDR (Abraham et al., 2009). Although both EC populations
expressed VE-cadherin, our data indicate that robust angiogenesis
in anterior ECs under flow conditions is correlated with
downregulation of VE-cadherin.
In addition to the molecular similarities and differences between
these EC subtypes, we show unique functional characteristics of
these populations in terms of their hemogenic capacity, consistent
with embryonic mesodermal patterning. Compared with anterior-
derived ECs, posterior-derived ECs were highly enriched in both
early hematopoietic activity, as judged by surface markers, and CFU
progenitors as assayed at day 5, as well as later, broader
erythromyeloid activity assayed following extended OP9 co-
culture with hematopoietic cytokines. These findings are
consistent with the embryonic origin of most hematopoietic
precursors from posterior mesoderm. Interestingly, we also
Fig. 7. RNA-seq analysis of cardiomyocytes generated from A100/B5 CPCs and A100/B5 ECsXAV. (A) Transcripts differentially expressed with FDR<0.05 are
highlighted in color: red, higher in cardiomyocytes derived fromA100/B5 CPCs; green, higher in cardiomyocytes derived fromA100/B5 ECsXAV. The subset of genes
with FDR<0.05 and fold-change >2 are considered significantly different. (B-D) Hand-collated list of genes associated with cell cycle, matrix, and signaling with
a greater than 2-fold difference (B), cardiac-associated genes that were not different between groups (C), and cardiac genes with a greater than 2-fold difference
(D) comparing A100/B5 CPCs (red) and A100/B5 ECsXAV (green). (E,F) Raw data for genes involved in cardiac development that are not different (E) or are
significantly different (F) between cardiomyocytes generated from A100/B5 CPCs (red) and A100/B5 ECsXAV (green). FPKM values are given.
3206
RESEARCH ARTICLE Development (2015) 142, 3198-3209 doi:10.1242/dev.117010
D
E
V
E
LO
P
M
E
N
T
observed limited, transient hematopoietic potential from anterior-
derived ECs. Although we cannot rule out contamination from a
small population of undifferentiated cells giving rise to these
hematopoietic progeny under hematopoiesis-inducing conditions
during OP9 co-culture, this finding could also be consistent with a
recent study showing transient hematopoietic potential from cells of
endocardial (anterior mesoderm) origin (Nakano et al., 2013).
Furthermore, the primarily primitive hematopoietic phenotype
observed from anterior-like cells is consistent with relatively
higher activin/nodal and lower Wnt/β-catenin signaling during the
mesodermal patterning of these cells, as recently shown to be
favorable for primitive hematopoiesis (Kennedy et al., 2012;
Sturgeon et al., 2014).
Our laboratory and others have shown that a failure to express key
molecules involved in fate decision in the developing endothelium
(e.g. TMEM88, SCL or Cloche) leads to the interconversion of cells
between the cardiac and endothelial fates at least in part through
regulation ofWnt/β-catenin signaling (Schoenebeck et al., 2007; Van
Handel et al., 2012; Palpant et al., 2013). This study shows that
generating ECs from prepatterned mesoderm results in a marked
cardiogenic lineage bias only in anterior-derived ECs. In particular,
we show that transient antagonism of Wnt/β-catenin signaling
facilitates the conversion of endothelium derived from anterior
mesoderm into cardiomyocytes. By contrast, endothelium derived
from posterior mesoderm showed no capacity for cardiogenic lineage
conversion after Wnt/β-catenin inhibition. More definitive assays in
the future should include in vitro lineage-tracing studies to confirm
these observations.
The capacity to direct the differentiation of high-purity progenitor
and definitive cell types from hPSCs is a critical step toward
understanding developmental mechanisms, disease etiology and
generating therapeutically relevant cell preparations. This study
shows that activin A and BMP4 are sufficient to direct the
polarization of mesoderm in vitro, which has marked consequences
for efficient cell fate specification into cardiac, endothelial and
hematopoietic lineages.
MATERIALS AND METHODS
Cell culture
Human ESCs and iPSCs were cultured onMatrigel (BDBiosciences) coated
plates and maintained in an undifferentiated state with either mouse
embryonic fibroblast (MEF)-conditioned media containing 5 ng/ml bFGF
(Peprotech, 100-18B) (for RUES2 hESCs, IMR90 hiPSCs, VN1 hiPSCs) or
defined media including X-Vivo (Lonza) (for ELF1 hESCs), or mTESR
(StemCell Technologies) (for RUES2 hESCs,WTC11 hiPSCs). A subset of
experiments was performed using RUES2 hESCs modified by lentivirus to
express the β-catenin-activated reporter BAR-Venus, as we described
previously (Palpant et al., 2013).
hESC directed differentiation
Standard cardiomyocyte directed differentiation using a monolayer
platform was performed with a modified protocol based on previous
reports (Laflamme et al., 2007; Paige et al., 2010; Lian et al., 2012).
Endothelial differentiation involved initiation of differentiation with
activin A and BMP4. On day 2, the medium was changed to a
composition adapted from work reported previously (Kennedy et al.,
2007): Stempro34 (Invitrogen, 10640019) containing 200 ng/ml VEGF
(Peprotech, 100-20), 5 ng/ml bFGF (Peprotech, 100-18B), 10 ng/ml
BMP4 (R&D Systems, 314-BP-050), 0.4 mM monothioglycerol, 50 µg/
ml ascorbic acid, 2 mM L-glutamine (Invitrogen, 25030-081) and Pen-
Strep (Invitrogen, 15140-163). Medium was not changed until day 5. For
additional information, see the supplementary Materials and Methods and
Fig. S6.
Colony-forming assays and hematopoietic differentiation onOP9
cells
OP9 feeder cells were seeded in 24-well plates the day prior to co-culture.
Day 5 unsorted or CD34+ sorted hESC-derived ECs were seeded onto OP9
cells at 1×105 cells per well in alpha-MEM (Invitrogen) with 10% FBS
(Hyclone), Pen-Strep (Invitrogen) and recombinant cytokines. Colonies
were scored by morphology after 12-14 days as small, primitive erythroid
(CFU-EryP), macrophage (CFU-Mac), granulocyte/monocyte/macrophage
(CFU-GM), large, burst-forming erythroid (BFU-E), or mixed colonies
containing both erythroid andmyeloid elements (CFU-Mix). For details, see
the supplementary Materials and Methods.
Endothelial cell differentiation and analysis
Unsorted or CD34+ sorted anterior- or posterior-derived ECs were plated in
gelatin-coated tissue culture flasks with EGM media (Lonza, CC-3124)
containing 20 ng/ml VEGF (Peprotech, 100-20), 20 ng/ml bFGF
(Peprotech, 100-18B) and 1 µM CHIR-99021 (Cayman Chemical,
13122). Cells were maintained until day 14, at which point cells were
isolated, analyzed by flow cytometry for CD31 expression, and then
assessed in assays for tube formation, angiogenesis, and fluid shear stress in
microfluidic channels as described in the supplementary Materials and
Methods.
Immunofluorescence
Cells were fixed, stained with primary antibodies then Alexa Fluor-
conjugated secondary antibodies (Invitrogen), and counterstained with
DAPI or Hoechst 33342 as described in the supplementary Materials and
Methods.
Quantitative (q) RT-PCR
Total RNA was isolated (from unsorted cell populations, unless specified
otherwise) using the RNeasy Miniprep Kit (Qiagen) and first-strand cDNA
synthesized using the Superscript III Reverse Transcriptase Kit (Invitrogen).
qPCR was performed using the Sensimix SYBR PCR Kit (Bioline) on a
7900HT fast real-time PCR system (Applied Biosystems). The copy number
for each transcript is expressed relative to HPRT. Primers are listed in
supplementary material Table S3.
Flow cytometry
BAR-Venus RUES2 cells were analyzed for intrinsic Venus fluorescence by
FACS. Wild-type RUES2 cells were labeled for flow cytometry using
antibodies as described in the supplementary Materials and Methods. Cells
were analyzed using a FACSCANTO II or sorted on a FACSARIA II with
FACSDiva software (BD Biosciences). Instrument settings were adjusted to
avoid spectral overlap. Data analysis was performed using FlowJo (Tree
Star). For further details of FACS and Wnt/β-catenin signaling analysis
using BAR-Venus see the supplementary Materials and Methods.
Proteomics
Peptides were isolated from cells and measured by nano-LC-MS/MS on a
Q Exactive (Thermo Scientific) equipped with a NanoAcquity system
(Waters) as described in the supplementary Materials and Methods.
Identification and label-free quantification of peptides were performed
with MaxQuant 1.3.0.5 using a 1% false discovery rate (FDR) against the
human Swiss-Prot/TrEMB database downloaded from Uniprot on October
11th, 2013. For further details see the supplementary Materials and
Methods.
RNA-seq
Samples were submitted to University of Washington High-Throughput
Genomic Sequencing Center for isolation and analysis. RNA-seq was
performed on poly-A-enriched samples using Illumina TruSeq.
Differentially expressed genes were classified according to gene ontology
using the NIAID Database for Annotation, Visualization and Integrated
Discovery (DAVID/EASE, http://david.abcc.ncifcrf.gov/). RNA-seq data
have been deposited in the NCBI Gene Expression Omnibus database with
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accession number GSE55275. Separately, FPKM (fragments per kilobase
of exon per million fragments mapped) values were computed using
Cufflinks version 2.1.1 (Trapnell et al., 2010) and UCSC gene annotations.
For additional information, see the supplementary Materials and Methods.
Statistics
Single variable analysis between two samples was compared by Student’s
t-test. Single and multivariable assays were analyzed by one-way or
two-way ANOVA. Results are presented as mean±s.e.m. P<0.05 was
considered significant.
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